BioCentury | Nov 23, 2009
Clinical News

Exhale Drug-Eluting Stents: Phase III data

...mL correlated with significant improvements in "multiple pulmonary function and emphysema symptom endpoints." Angiotech granted Broncus...
...system in 2005 (see BioCentury, June 6, 2005). Angiotech Pharmaceuticals Inc. (TSX:ANP; NASDAQ:ANPI), Vancouver, B.C. Broncus Technologies Inc....
BioCentury | Dec 8, 2008
Finance

Ebb & Flow

...and reimbursement claims. Last week, Abingworth also participated in the $38 million financing completed by Broncus...
...Charter Ventures; HBM BioVentures JAIC America; Menlo Ventures; Pac-Link Ventures; Saints Capital and Sightline Ventures. Broncus'...
BioCentury | Jun 6, 2005
Company News

Angiotech, Broncus deal

...ANP granted Broncus a worldwide, non-exclusive license to use paclitaxel technology with Broncus' Exhale system to...
...ANP will receive an upfront payment and milestones in the form of warrants to purchase Broncus...
...preferred stock. ANP also is eligible for royalties. Angiotech Pharmaceuticals Inc. (TSE:ANP; ANPI), Vancouver, B.C. Broncus Technologies Inc....
Items per page:
1 - 3 of 3
BioCentury | Nov 23, 2009
Clinical News

Exhale Drug-Eluting Stents: Phase III data

...mL correlated with significant improvements in "multiple pulmonary function and emphysema symptom endpoints." Angiotech granted Broncus...
...system in 2005 (see BioCentury, June 6, 2005). Angiotech Pharmaceuticals Inc. (TSX:ANP; NASDAQ:ANPI), Vancouver, B.C. Broncus Technologies Inc....
BioCentury | Dec 8, 2008
Finance

Ebb & Flow

...and reimbursement claims. Last week, Abingworth also participated in the $38 million financing completed by Broncus...
...Charter Ventures; HBM BioVentures JAIC America; Menlo Ventures; Pac-Link Ventures; Saints Capital and Sightline Ventures. Broncus'...
BioCentury | Jun 6, 2005
Company News

Angiotech, Broncus deal

...ANP granted Broncus a worldwide, non-exclusive license to use paclitaxel technology with Broncus' Exhale system to...
...ANP will receive an upfront payment and milestones in the form of warrants to purchase Broncus...
...preferred stock. ANP also is eligible for royalties. Angiotech Pharmaceuticals Inc. (TSE:ANP; ANPI), Vancouver, B.C. Broncus Technologies Inc....
Items per page:
1 - 3 of 3